Rebollo-Roman, AngelAlhambra-Exposito, Maria R.Herrera-Martinez, YiraldineLeiva-Cepas, F.Alzas, CarlosMuñoz-Jimenez, ConcepcionOrtega-Salas, R.Molina-Puertas, Maria J.Galvez-Moreno, Maria A.Herrera-Martinez, Aura D.2023-02-092023-02-092021-06-04Rebollo-Román A, Alhambra-Expósito MR, Herrera-Martínez Y, Leiva-Cepas F, Alzas C, Muñoz-Jiménez C, et al. Catecholaminergic Crisis After a Bleeding Complication of COVID-19 Infection: A Case Report. Front Endocrinol (Lausanne). 2021 Sep 8;12:6930041664-2392http://hdl.handle.net/10668/18542The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents in some cases with hemostatic and thrombotic complications. Pheochromocytomas are unusual, though potentially lethal tumors. Herein we describe the first case of hemorrhage in a pheochromocytoma related to SARS-CoV-2 infection. A 62-year-old man consulted for syncope, fever, and palpitations. He was diagnosed with SARS-CoV-2 pneumonia and presented with a hemorrhage in a previously unknown adrenal mass, which resulted in a catecholaminergic crisis. Medical treatment and surgery were required for symptom control and stabilization. We hereby alert clinicians to watch for additional/unreported clinical manifestations in COVID-19 infection.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/COVID19BleedingCatecholaminesComplicationPheochromocytomaAdrenal Gland NeoplasmsCOVID-19HemorrhageHumansMaleMiddle AgedPheochromocytomaPneumoniaresearch article34566886open accessHumanosHemorragiaFeocromocitomaNeoplasias de las glandulas suprarrenalesNeumoniaPersona de mediana edadMasculino10.3389/fendo.2021.693004PMC8456100https://www.frontiersin.org/articles/10.3389/fendo.2021.693004/pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456100/pdf